e-learning
resources
London 2016
Tuesday, 06.09.2016
Novel avenues in the treatment of COPD II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Glaucoma risk due to antimuscarinics, not a class effect: A systematic review
Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez
Source:
International Congress 2016 – Novel avenues in the treatment of COPD II
Session:
Novel avenues in the treatment of COPD II
Session type:
Thematic Poster
Number:
4069
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez. Glaucoma risk due to antimuscarinics, not a class effect: A systematic review. Eur Respir J 2016; 48: Suppl. 60, 4069
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Educational inhaler technique interventions in asthma & COPD patients: A systematic review
Source: International Congress 2016 – Management of asthma and COPD in primary care
Year: 2016
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Patients’ opinion for their inhalation device. An assessment of convenience and use
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Real-life study on the aPpropriaTeness of treatment in moderate COPD patients (OPTIMO)
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014
Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Inhaled treatment of COPD: A delphi consensus statement
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Differences in adherence to common inhaled medications in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Vitamin D for the management of asthma: Cochrane systematic review and meta-analysis
Source: International Congress 2016 – Asthma management
Year: 2016
GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Contraindications and precautions with inhalation therapy in COPD. Awareness or unawareness, a questionaire
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept